Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507026 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 277
- Enrollment target
NCT00507026 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 277 participants.
The verdict
NCT00507026, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 277 participants
- Enrollment target
Study Summary
This study will compare repeated intermittent IV dosing of diclofenac in patient with moderate to severe post-surgical pain from elective orthopedic surgery.
Interventions
- DRUG Placebo
- DRUG IV Diclofenac
- DRUG IV ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2007-07-25 |
| Est. Completion | 2008-10-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507026
The ClinicalTrials.gov registry entry for NCT00507026 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00507026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507026 about?
NCT00507026 is a clinical study titled "Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery". This study will compare repeated intermittent IV dosing of diclofenac in patient with moderate to severe post-surgical pain from elective orthopedic surgery.
What is the current status of trial NCT00507026?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 277 participants. The study started on 2007-07-25. Estimated completion is 2008-10-14.
What interventions are being tested in trial NCT00507026?
The interventions under investigation include: Placebo (DRUG), IV Diclofenac (DRUG), IV ketorolac (DRUG).
Who is sponsoring clinical trial NCT00507026?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.